These presentations contain "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, future operating and financial performance, product development, market position, business strategy and restructuring plans. These statements use words, and variations of words, such as "will," "expect," "next," "project," "potential," "continue," "expand" and "grow". You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty.
If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Johnson & Johnson. Risks and uncertainties include, but are not limited to: economic factors, such as interest rate and currency exchange rate fluctuations; competition, including technological advances, new products and patents attained by competitors; challenges inherent in product development, including uncertainty of clinical success and obtaining regulatory approvals; challenges to patents; the impact of patent expirations; uncertainty of commercial success of new and existing products; significant adverse litigation or government action, including related to product liability claims; the ability of the company to successfully execute strategic plans including restructuring plans; the impact of business combinations and divestitures; significant changes in customer relationships or in behavior and spending patterns of purchasers of health care products and services; financial distress and bankruptcies experienced by significant customers and suppliers; changes to laws and regulations, including tax laws and global health care reforms; trends toward health care cost containment; financial instability of international economies and legal systems and sovereign risk; manufacturing difficulties or delays, internally or within the supply chain; increased scrutiny of the health care industry by government agencies; product efficacy or safety concerns resulting in product recalls or regulatory action; and the potential failure to meet obligations in compliance agreements with government bodies.
A further list and description of these risks, uncertainties and other factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 3, 2016, including in Exhibit 99 thereto, and the company's subsequent filings with the Securities and Exchange Commission. Copies of these filings are available online at www.sec.gov, www.investor.jnj.com or on request from Johnson & Johnson. Information in each of these presentations is as of the dates and time periods indicated therein, and Johnson & Johnson does not undertake to update any of the information contained in these materials. Accordingly, YOU SHOULD NOT RELY ON THE ACCURACY OF ANY OF THE STATEMENTS OR OTHER INFORMATION CONTAINED IN ANY ARCHIVED WEBCASTS OR ON DEMAND VIDEOS.
Webcasts on this website are the property of Johnson & Johnson. Any redistribution, retransmission or rebroadcast of this webcast in any form without the express written consent of Johnson & Johnson is strictly prohibited. Please see our Legal Notice for more information about the content of this website and copyright laws.